Calviri

Calviri is a company that develops diagnostic and therapeutic products, as well as vaccines aimed to prevent cancer. Its approach is based on the discovery of an unrecognized source of frameshift neoantigens. These immunogenic peptides are generated from frequent errors in tumor-cell RNA synthesis and processing. They provide both cancer-specific and shared frameshift neoantigens for a new class of diagnostic and vaccine products.